Division of Royal Philips NV
Latest From Philips Healthcare
Dutch health giant Philips reported Q2 results 22 July, showing better-than-expected sales across its medtech businesses. Strong growth in China and North America boosted the firm’s diagnosis and treatment businesses by 6% from the same period last year.
Exec Chat: Philips's Bert Van Meurs Discusses Innovation And Plans For Image-Guided Therapy Business Unit
This year, Bert van Meurs, chief business leader of Philips's image-guided therapy business, has led two major product launches and a new partnership with Microsoft to combine Philips's Azurion angiographic platform with Microsoft's HoloLens 2 mixed-reality (MR) technology. Medtech Insight caught up with van Meurs to learn more about Azurion, the continued role of machine learning and MR, the overall business strategy and competitive landscape.
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week’s approvals include the FDA’s approval of new non-adjunctive labeling for Senseonics’ Eversense continuous glucose monitor and a de novo for Innovative Health Solutions’ IB-Stim percutaneous electrical nerve field stimulator to treat pain associated with irritable bowel syndrome.
Turkey’s health ministry has disclosed that the forthcoming $10bn medical device tender must come with conditions that strengthen the local manufacturing infrastructure. It must also give Turkey “real” technology with IP rights, not merely an assembly activity for parts manufactured abroad. The tender will be ready in some two to three months.
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
- Monitoring Equipment & Devices
- Diagnostic Imaging Equipment & Supplies
- Therapeutic Areas
- Philips Medical Systems Inc.
- North America
- Parent & Subsidiaries
- Royal Philips NV
- Senior Management
Deborah DiSanzo, EVP, CEO
Abhijit Bhattacharya, EVP, CFO
- Contact Info
Phone: (978) 659-3000
3000 Minuteman Rd.
Andover, MA 01810-1099
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.